Synakis Corp
Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage
CA$2.6MPre-Seed
Role not disclosedLoading investors…
Activity from announced rounds
Develops hydrogel-based ocular therapies for retinal detachment and glaucoma in pre-clinical stage